IMJUDO C Code: C9147

Drug & Product Overview

HCPCS Descriptor Injection, tremelimumab-actl, 1 mg

HCPCS Added Date April 1, 2023

Manufacturer Astrazeneca

Route of Administration Intravenous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection, Solution

About IMJUDO

Imjudo is a medication aligned to the HCPCS C Code: C9147 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Astrazeneca.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to C9147. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	IMJUDO
	IMJUDO

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

IMJUDO CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Imjudo (C9147) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9147. Wastage billing guide →

IMJUDO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Metastatic non-small cell lung cancer Unresectable hepatocellular carcinoma

Drug Class

CTLA-4-directed Antibody Interactions [MoA]CTLA-4-directed Blocking Antibody [EPC]Increased T Lymphocyte Activation [PE]

Frequently Asked Questions

Is there an available Imjudo billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for IMJUDO.

Are there any available Imjudo patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for IMJUDO.

Where can I find Imjudo prescribing information?

IMJUDO prescribing information can be found at the link below: Visit Here →

Where can I find Imjudo side effect information?

Information regarding IMJUDO's side effects can be found at MedlinePlus Visit Here →

Does billing IMJUDO require JZ/JW wastage modifiers?

CMS does not include IMJUDO (C9147) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9147. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.